Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Measuring interleukin 23 in people with lupus-related lung disease

Measures interleukin 23 in the blood of adults with lupus-related lung disease.

Plain-language title generated from the registry record
Registry title: Interleukin23 in Systemic Lupus

Key facts

Where
Sohag, EgyptSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Source: NCT06713187, who can take part

Where in Egypt

  • Sohag UniversitySohag, EgyptTaking people
  • Sohag University HospitalSohag, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT06713187
Record updated
3 December 2024
Original description
assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .Read full original descriptionShow less

Role of Interleukin 23 in Systemic Lupus Erythematosus Related Interstial Lung Disease

assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .

Inclusion: patients with systemic lupus erythematous and patients with systemic lupus erythematosus with interstial lung disease.

Exclusion: patients with chest conditions rather than interstial lung disease \&who receiving biological blocking antibodies\& those treated with immunosuppressive drugs.

ClinicalTrials.gov NCT06713187